Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials-Reference-Cited by-同舟云学术

Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials

Published:2014-07 Issue:7 Volume:106 Page:
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Donovan Kristine A.,Donovan Heidi S.,Cella David,Gaines Martha E.,Penson Richard T.,Plaxe Steven C.,von Gruenigen Vivian E.,Bruner Deborah Watkins,Reeve Bryce B.,Wenzel Lari

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/7/dju128/18614732/dju128.pdf

Reference35 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2012

2. Standard treatment in advanced ovarian cancer in 2005: the state of the art;Bookman;Int J Gynecol Cancer,2005

3. Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit;Ozols;J Clin Oncol,2003

4. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards;Cleeland;J Pain Symptom Manage,2010

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A qualitative analysis of algorithm-based decision support usability testing for symptom management across the trajectory of cancer care: one size does not fit all;BMC Medical Informatics and Decision Making;2024-03-05

2. Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study;BMJ Open;2024-01

3. Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer;Supportive Care in Cancer;2023-12-28

4. Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer;Gynecologic Oncology;2023-10

5. A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy;Journal of Patient-Reported Outcomes;2023-07-18